JP6940407B2 - フェンタニルを含む経皮薬物送達デバイス - Google Patents

フェンタニルを含む経皮薬物送達デバイス Download PDF

Info

Publication number
JP6940407B2
JP6940407B2 JP2017532823A JP2017532823A JP6940407B2 JP 6940407 B2 JP6940407 B2 JP 6940407B2 JP 2017532823 A JP2017532823 A JP 2017532823A JP 2017532823 A JP2017532823 A JP 2017532823A JP 6940407 B2 JP6940407 B2 JP 6940407B2
Authority
JP
Japan
Prior art keywords
weight
fentanyl
copolymer
drug delivery
delivery device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017532823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017538735A5 (enExample
JP2017538735A (ja
Inventor
プリンス，エイミー プレツラー
プリンス，エイミー プレツラー
カンター，アダム　エス．
エス． カンター，アダム
ジェイ． ウォール，スティーブン
ジェイ． ウォール，スティーブン
アール． ハート，ジョン
アール． ハート，ジョン
ピー． ディジオ，ジェイムズ
ピー． ディジオ，ジェイムズ
シコラ，サラ
エル． ハズバーグ，マイケル
エル． ハズバーグ，マイケル
Original Assignee
キンデーバ ドラッグ デリバリー リミティド パートナーシップ
キンデーバ ドラッグ デリバリー リミティド パートナーシップ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キンデーバ ドラッグ デリバリー リミティド パートナーシップ, キンデーバ ドラッグ デリバリー リミティド パートナーシップ filed Critical キンデーバ ドラッグ デリバリー リミティド パートナーシップ
Publication of JP2017538735A publication Critical patent/JP2017538735A/ja
Publication of JP2017538735A5 publication Critical patent/JP2017538735A5/ja
Application granted granted Critical
Publication of JP6940407B2 publication Critical patent/JP6940407B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2017532823A 2014-12-19 2015-12-17 フェンタニルを含む経皮薬物送達デバイス Active JP6940407B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462094659P 2014-12-19 2014-12-19
US62/094,659 2014-12-19
PCT/US2015/066453 WO2016100708A1 (en) 2014-12-19 2015-12-17 Transdermal drug delivery device including fentanyl

Publications (3)

Publication Number Publication Date
JP2017538735A JP2017538735A (ja) 2017-12-28
JP2017538735A5 JP2017538735A5 (enExample) 2019-01-31
JP6940407B2 true JP6940407B2 (ja) 2021-09-29

Family

ID=56127620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017532823A Active JP6940407B2 (ja) 2014-12-19 2015-12-17 フェンタニルを含む経皮薬物送達デバイス

Country Status (5)

Country Link
US (1) US20180263920A1 (enExample)
EP (1) EP3233081B1 (enExample)
JP (1) JP6940407B2 (enExample)
CN (1) CN107106552A (enExample)
WO (1) WO2016100708A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020084380A1 (en) 2018-10-23 2020-04-30 3M Innovative Properties Company Tamper evident transdermal patch
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12029562B2 (en) 2021-04-14 2024-07-09 Satio, Inc. Dermal patch system
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT610737A (enExample) 1955-11-18 1900-01-01
US3097008A (en) * 1961-08-14 1963-07-09 Arthur J Gravelle Latch guard
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4693776A (en) 1985-05-16 1987-09-15 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive
US4732808A (en) 1985-11-14 1988-03-22 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive sheet material
DE69517816T2 (de) 1994-09-14 2000-12-28 Minnesota Mining & Mfg Matrix für transdermale wirkstofffreisetzung
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
KR100904158B1 (ko) 2001-03-16 2009-06-23 알자 코포레이션 펜타닐 투여용 경피성 패치
JP3642316B2 (ja) * 2001-06-15 2005-04-27 日本電気株式会社 化学増幅レジスト用単量体、化学増幅レジスト用重合体、化学増幅レジスト組成物、パターン形成方法
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE50310279D1 (de) 2002-03-06 2008-09-18 Hexal Ag Transdermalsystem mit fentanyl
AU2003230034A1 (en) * 2002-05-15 2003-12-02 Thalas Group Incorporated Transdermal delivery device for the administration of fentanyl
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
WO2003101433A1 (de) 2002-05-28 2003-12-11 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend fentanylum
EP2319505A1 (en) * 2003-04-30 2011-05-11 Purdue Pharma L.P. Transdermal dosage form comprising an active agent component and an adverse agent component in a ratio from 1:10 up to 10:1
TW200745492A (en) * 2006-02-22 2007-12-16 Takiron Co Surface light-emitting device
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
RU2499583C2 (ru) * 2007-10-15 2013-11-27 Алза Корпорейшн Заместительное трансдермальное введение фентанила один раз в день
WO2009051217A1 (ja) * 2007-10-17 2009-04-23 Hisamitsu Pharmaceutical Co., Inc. フェンタニル含有経皮吸収製剤
CN101780057B (zh) * 2009-01-21 2012-09-05 考司美德制药株式会社 经皮吸收贴剂
WO2011010556A1 (ja) * 2009-07-23 2011-01-27 ニプロパッチ株式会社 経皮吸収型製剤
WO2012012417A1 (en) * 2010-07-21 2012-01-26 3M Innovative Properties Company Transdermal adhesive compositions, devices, and methods
KR20120107153A (ko) * 2011-03-15 2012-10-02 아이큐어 주식회사 펜타닐 경피 패치제
EP2711002A4 (en) * 2011-05-20 2014-10-29 Sk Chemicals Co Ltd PLASTER WITH RIVASTIGMIN
US20140243765A1 (en) * 2011-09-22 2014-08-28 Samyang Biopharmaceuticals Corporation Percutaneously absorbable preparation containing fentanyl and homologue thereof
EP2599478A1 (de) * 2011-11-30 2013-06-05 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon

Also Published As

Publication number Publication date
US20180263920A1 (en) 2018-09-20
CN107106552A (zh) 2017-08-29
EP3233081B1 (en) 2021-09-22
EP3233081A4 (en) 2018-07-04
JP2017538735A (ja) 2017-12-28
WO2016100708A1 (en) 2016-06-23
EP3233081A1 (en) 2017-10-25

Similar Documents

Publication Publication Date Title
JP6940407B2 (ja) フェンタニルを含む経皮薬物送達デバイス
JP6437908B2 (ja) フェンタニルの経皮デリバリのための組成物
AU735944B2 (en) Transdermal device for the delivery of testosterone
AU2002215315A1 (en) Composition for the transdermal delivery of fentanyl
JP5209433B2 (ja) 貼付製剤
JP4194277B2 (ja) 架橋ポリマーを主成分とする粘着性成形体の製造方法
JPWO2006093066A1 (ja) 粘着基材及び該粘着基材を含む医療用貼付製剤
HUP0203282A2 (hu) (R)-(Z)-1-aza-biciklo[2.2.1]hepton-3-on.0-[3-(3-metoxifenil)-2-propinil)-oxim gyógyszer transzdermális adagolására alkalmas eszközök
WO2021166986A1 (ja) 貼付製剤
WO2007011763A2 (en) Adhesive sheet and methods of use thereof
HK1059225A (en) Composition for the transdermal delivery of fentanyl
WO2014159778A1 (en) Transdermal drug delivery system containing fentanyl
AU2010202646A1 (en) Composition for the transdermal delivery of fentanyl

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190827

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200630

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201030

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20201030

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20201109

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20201110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210402

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20210514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210628

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210803

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210902

R150 Certificate of patent or registration of utility model

Ref document number: 6940407

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250